Journal article

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017

Angie Lackenby, Terry G Besselaar, Rod S Daniels, Alicia Fry, Vicki Gregory, Larisa V Gubareva, Weijuan Huang, Aeron C Hurt, Sook-Kwan Leang, Raphael TC Lee, Janice Lo, Lori Lollis, Sebastian Maurer-Stroh, Takato Odagiri, Dmitriy Pereyaslov, Emi Takashita, Dayan Wang, Wenqing Zhang, Adam Meijer

ANTIVIRAL RESEARCH | ELSEVIER | Published : 2018

Grants

Awarded by National Key Re-search and Development Program of China


Awarded by Francis Crick Institute from Cancer Research UK


Awarded by Medical Reseach Council


Awarded by Wellcome Trust


Awarded by JSPS KAKENHI Grant


Awarded by BMRC FluSurver grant


Awarded by Advanced Molecular Detection (AMD) Program, CDC


Funding Acknowledgements

The Beijing WHO CC received grants from National Key Re-search and Development Program of China (2016YFD0500208). The London CC, the Crick Worldwide Influenza Centre, is supported by the Francis Crick Institute receiving core funding from Cancer Research UK (FC001030), the Medical Reseach Council (FC001030) and the Wellcome Trust (FC001030). The Melbourne CC is supported by the Australian Government, Department of Health. The Tokyo CC is supported by Grants-in-Aid for Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare, Japan and by JSPS KAKENHI Grant number 18K10036. RTCL and SMS are supported by the-BMRC FluSurver grant (H16/99/b0/013). The Atlanta CC received grants (#AMD-77 and #AMD-102) from the Advanced Molecular Detection (AMD) Program, CDC, to establish the next generation sequencing and bioinformatics support for influenza viruses.